Tilray Brands (TSE:TLRY) Given New C$13.60 Price Target at Sanford C. Bernstein

Tilray Brands (TSE:TLRY) had its price objective hoisted by equities research analysts at Sanford C. Bernstein from C$13.00 to C$13.60 in a research note issued on Friday,BayStreet.CA reports. Sanford C. Bernstein’s price objective suggests a potential downside of 13.27% from the stock’s previous close.

Tilray Brands Trading Down 7.5%

TSE TLRY traded down C$1.28 during trading hours on Friday, reaching C$15.68. The company had a trading volume of 961,586 shares, compared to its average volume of 332,469. The company has a current ratio of 2.54, a quick ratio of 2.16 and a debt-to-equity ratio of 10.76. The stock has a market capitalization of C$1.82 billion, a P/E ratio of -0.65 and a beta of 3.56. The stock has a 50-day moving average of C$16.56 and a 200 day moving average of C$13.74. Tilray Brands has a 1-year low of C$4.90 and a 1-year high of C$32.30.

About Tilray Brands

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.